Felbatol 400 MG Oral Tablet
- RxCUI
- 209026
- RxNorm name
- Felbatol 400 MG Oral Tablet
- Display name
- Felbatol 400 MG Oral Tablet
- Full name
- Felbatol 400 MG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:52
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Felbatol | FELBAMATE | Viatris Specialty LLC | 2f522701-397a-11de-8a39-0800200c9a66 | 2025-08-15 | Boxed warning, Warnings, Adverse reactions | 209026 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2f522701-397a-11de-8a39-0800200c9a66 | Felbatol 400 MG Oral Tablet [PSN] · felbamate 400 MG Oral Tablet [Felbatol] [SBD] · Felbatol 400 MG Oral Tablet [SY] · FELT 400 MG Oral Tablet [Felbatol] [SY] | 4 | 16 | Before Prescribing Felbatol® (felbamate), the physician should be thoroughly familiar with the details of this prescribing information. FELBATOL® SHOULD NOT BE USED BY PATIENTS UNTIL THERE HAS BEEN A COMPLETE DISCUSSION OF THE RISKS AND THE PATIENT, PARENT, OR GUARDIAN HAS BEEN PROVIDED THE FELBATOL WRITTEN ACKNOWLEDGEMENT (SEE PATIENT/PHYSICIAN ACKNOWLEDGMENT FORM). | 20250815 |